NCT04315831 Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain Status COMPLETED Phase N/A
NCT04314479 Improving Adherence to ACS Guidelines on Nutrition and Physical Activity in Latinas With Cancer and Their Informal Caregivers Status COMPLETED Phase NA
NCT04309240 Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports Status UNKNOWN Phase PHASE3
NCT04306562 Effect of Oral Protein Supplementation on Postoperative Complications in Elderly Sarcopenic Cancerous Patients Status TERMINATED Phase NA
NCT04301765 Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency Status RECRUITING Phase PHASE2
NCT04301362 Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients Status UNKNOWN Phase N/A
NCT04300244 Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04299230 Continous Monitoring of Vital Signs on Hospitalized Cancer Patients. Status COMPLETED Phase N/A
NCT04298398 Impact of Group Psychological Interventions on Extracellular Vesicles in People Who Had Cancer Status UNKNOWN Phase NA
NCT04295668 PAPRIKA - Patients Empowerment for Major Surgery Preparation @Home Status UNKNOWN Phase N/A
NCT04294550 Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol Status COMPLETED Phase N/A
NCT04292678 The Effect of Progressive Relaxation Exercise on Caregiver Burden, Fatigue and Quality of Life in Caregivers of Patients With Advanced Cancer: Randomized Controlled Clinical Study Status UNKNOWN Phase NA
NCT04291079 SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON) Status COMPLETED Phase PHASE1
NCT04285996 IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types Status COMPLETED Phase NA
NCT04285242 Metabolic and Immunological Phenotyping in Patients With Cancer Status RECRUITING Phase N/A
NCT04283539 Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy Status RECRUITING Phase N/A